EUVIMEDEUVIMED entdecken
Crossref

Artemisia monosperma essential oil nanoformulations alleviate imiquimod-induced psoriasis-like dermatitis in mice

Nashwa F Tawfik, Rania S Abdel-Rashid, Elsayed K El-Sayed, Raghda Abdel-Moneum, Mohamed A Khattab, Asmaa A Ahmed, Kuei-Hung Lai, Nashwa Hashad, Fatma A Moharram

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Nashwa F Tawfik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Helwan University., Cairo 11795, Egypt. Hauptthemen laut MEDLINE: Psoriasis, Imiquimod, Artemisia, Oils, Volatile. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: National Science and Technology Council, Ministry of Science and Technology, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is an inflammatory immune-mediated skin disease that affects nearly 2-3 % of the global population. The current study aimed to develop safe and efficient anti-psoriatic nanoformulations from Artemisia monosperma essential oil (EO). EO was extracted using hydrodistillation (HD), microwave-assisted hydrodistillation (MAHD), and head-space solid-phase microextraction (HS-SPME), as well as GC/ MS was used for its analysis. EO nanoemulsion (NE) was prepared using the phase inversion method, while the biodegradable polymeric film (BF) was prepared using the solvent casting technique. A.monosperma EO contains a high percentage of non-oxygenated compounds, being 90.45 (HD), 82.62 (MADH), and 95.17 (HS-SPME). Acenaphthene represents the major aromatic hydrocarbon in HD (39.14 %) and MADH (48.60 %), while sabinene as monoterpene hydrocarbon (44.2 %) is the primary compound in the case of HS-SPME. The anti-psoriatic Effect of NE and BF on the successful delivery of A.monosperma EO was studied using the imiquimod (IMQ)-induced psoriatic model in mice. Five groups (n = 6 mice) were classified into control group, IMQ group, IMQ+standard group, IMQ+NE group, and IMQ+BF group. NE and BF significantly alleviated the psoriatic skin lesions and decreased the psoriasis area severity index, Baker's score, and spleen index. Also, they reduced the expression of Ki67 and attenuated the levels of tumor necrosis factor-alpha, interleukin 6, and interleukin 17. Additionally, NE and NF were able to downregulate the NF-κB and GSK-3β signaling pathways. Despite the healing properties of BF, NE showed a more prominent effect on treating the psoriatic model, which could be referred to as its high skin penetration ability and absorption. These results potentially contribute to documenting experimental and theoretical evidence for the clinical uses of A.monosperma EO nanoformulations for treating psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisImiquimodArtemisiaOils, VolatileAnimalsMiceHumansSkinDisease Models, AnimalCytokinesNanoparticlesMice, Inbred BALB CFemaleMaleAnti-Inflammatory AgentsEmulsions

Stichwörter der Autor:innen

Biodegredable polymeric filmHead-space solid-phase microextractionHydrodistillationMicrowave-assisted hydro-distillationNanoemulsionPsoriasis

Substanzen

ImiquimodOils, VolatileCytokinesAnti-Inflammatory AgentsEmulsions

Autor:innen und Institutionen

  • Department of Pharmacognosy, Faculty of Pharmacy, Helwan University., Cairo 11795, Egypt.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt.
  • Department of Cytology and Histology, Faculty of Veterinary Medicine, Cairo University, Egypt.
  • Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan; PhD Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Tai…

Förderung

  • National Science and Technology Council
  • Ministry of Science and Technology, Taiwan

Zitieren

APA

Tawfik, N. F., Abdel-Rashid, R. S., El-Sayed, E. K., Abdel-Moneum, R., Khattab, M. A., Ahmed, A. A., Lai, K. H., Hashad, N., & Moharram, F. A. (2024). Artemisia monosperma essential oil nanoformulations alleviate imiquimod-induced psoriasis-like dermatitis in mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112733

Vancouver

Tawfik NF, Abdel-Rashid RS, El-Sayed EK, Abdel-Moneum R, Khattab MA, Ahmed AA, et al. Artemisia monosperma essential oil nanoformulations alleviate imiquimod-induced psoriasis-like dermatitis in mice. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112733

BibTeX
@article{Tawfik2024,
  author = {Tawfik, Nashwa F and Abdel-Rashid, Rania S and El-Sayed, Elsayed K and Abdel-Moneum, Raghda and Khattab, Mohamed A and Ahmed, Asmaa A and Lai, Kuei-Hung and Hashad, Nashwa and Moharram, Fatma A},
  title = {Artemisia monosperma essential oil nanoformulations alleviate imiquimod-induced psoriasis-like dermatitis in mice},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112733}
}
Kostenlos starten →